http://www.lexology.com/library/detail.aspx?g=66437b46-9961-455e-aacf-572f930796f2
The Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union was approved by all 28 EU member states in October 2016, and was signed promptly thereafter by Canadian Prime Minister Justin Trudeau. Under CETA, Canada has promised, inter alia, to make a number of important changes to intellectual property protection for pharmaceutical patentees in order to bring Canadian practice more in line with European practice.
No comments:
Post a Comment